Skip to main content

What's New

Information lacking on remote abortion-care options

Abortion medication delivered by mail
Many don’t know remote options include FDA-approved medications and online conferencing with licensed clinicians, a newly published paper suggests.

News Releases

Test strips detect the presence of xylazine

Researchers develop antibodies against xylazine's harms

The antibodies target the fourth wave of the drug epidemic, as mixed drug use with sedative xylazine surges nationally.
A child uses a smartphone to check blood sugar with a continuous glucose monitor.

Biopsies reveal breadth of drug’s kidney protection

Medication reversed molecular signs of early kidney damage in youth with type 1 diabetes, study findings show.
 Pseudomonas aeruginosa bacterial colonies from a person with cystic fibrosis growing on agar plates

Partners in crime produce extreme antibiotic resistance

Environmental bacteria enter lungs during an infection and transfer antibiotic resistance genes to disease-causing bacteria.
A doctor and a patient sit in discussion in an exam room.

Secondary care gap tied to prostate cancer deaths

Black men who did not receive secondary treatment were up to twice as likely to die of prostate cancer as white men.
Dr. Colin Pritchard in his cancer molecular diagnostics

Gene variant linked to risk of aggressive prostate cancer

Study findings suggest that the variant should be added to tests that identify cancer risks.

picture of Nathan Hyun and Tim Griffis

How to Reach Us

Journalists may reach the media relations team via email (mediarelations@uw.edu) from 8 a.m. to 5 p.m. PT. For urgent media requests after business hours, reach our on-call representative at 206-669-0164.

If you need us to record an on-camera interview with a UW Medicine expert, please email your request with specific details.

Contact Us

Reporters: For interviews with clinicians, researchers and instructors, reach our team. mediarelations@uw.edu